[go: up one dir, main page]

GB2021409A - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
GB2021409A
GB2021409A GB7826390A GB7826390A GB2021409A GB 2021409 A GB2021409 A GB 2021409A GB 7826390 A GB7826390 A GB 7826390A GB 7826390 A GB7826390 A GB 7826390A GB 2021409 A GB2021409 A GB 2021409A
Authority
GB
United Kingdom
Prior art keywords
composition
pharmaceutical composition
pharmaceutical
sulphasalazine
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB7826390A
Other versions
GB2021409B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fisons Ltd
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons Ltd filed Critical Fisons Ltd
Priority to GB7826390A priority Critical patent/GB2021409B/en
Publication of GB2021409A publication Critical patent/GB2021409A/en
Application granted granted Critical
Publication of GB2021409B publication Critical patent/GB2021409B/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
    • A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A pharmaceutical composition comprising a compound having sodium cromoglycate like activity, as active ingredient, in combination with sulphasalazine, or with an aminosalicyclic acid or a pharmaceutically acceptable derivative thereof, packages containing the separate components of the composition and pharmaceutical formulations containing the composition.
GB7826390A 1977-05-25 1978-06-06 Pharmaceutical composition Expired GB2021409B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB7826390A GB2021409B (en) 1977-05-25 1978-06-06 Pharmaceutical composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB85479 1977-05-25
GB7826390A GB2021409B (en) 1977-05-25 1978-06-06 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
GB2021409A true GB2021409A (en) 1979-12-05
GB2021409B GB2021409B (en) 1982-09-22

Family

ID=26236228

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7826390A Expired GB2021409B (en) 1977-05-25 1978-06-06 Pharmaceutical composition

Country Status (1)

Country Link
GB (1) GB2021409B (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
WO1983000435A1 (en) * 1981-07-31 1983-02-17 Rhodes, John Orally administrable pharmaceutical compositions
EP0062000A3 (en) * 1981-03-18 1983-07-27 Stafford-Miller Continental Use of 4-aminosalicylic acid as an anti-inflammatory agent
US4540685A (en) * 1981-12-23 1985-09-10 Bauer Kurt H Process for the production of readily soluble 5-aminosalicylic acid preparations, compositions and methods of use
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
US5120306A (en) * 1990-03-21 1992-06-09 Gosselin Leon F Direct delivery of anti-inflammatories to the proximal small bowel
GB2253346A (en) * 1991-02-22 1992-09-09 John Rhodes Delayed release oral dosage forms for treatment of intestinal disorders
EP0291159A3 (en) * 1987-04-01 1993-03-17 Dak-Laboratoriet A/S Aminosalicylic-acid derivatives for the treatment of psoriasis
EP0554291A4 (en) * 1990-10-22 1993-09-08 Thomas Julius Borody Treatment of non-inflammatory and non-infectious bowel disorders
US5519014A (en) * 1990-10-22 1996-05-21 Borody; Thomas J. Treatment of non-inflammatory and non-infectious bowel disorders

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002671A1 (en) * 1980-03-20 1981-10-01 Ferring Farma Lab Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
US4880794A (en) * 1980-03-20 1989-11-14 Soren Halskov Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration
US4960765A (en) * 1980-03-20 1990-10-02 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
US4980173A (en) * 1980-03-20 1990-12-25 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
US5013727A (en) * 1980-03-20 1991-05-07 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
US5041431A (en) * 1980-03-20 1991-08-20 Farmaceutisk Laboratorium Ferring A/S Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
EP0062000A3 (en) * 1981-03-18 1983-07-27 Stafford-Miller Continental Use of 4-aminosalicylic acid as an anti-inflammatory agent
US4440763A (en) * 1981-03-18 1984-04-03 Block Drug Company, Inc. Use of 4-aminosalicyclic acid as an anti-inflammatory agent
US5541171A (en) * 1981-07-31 1996-07-30 Tillotts Pharma Ag Orally administrable pharmaceutical composition
WO1983000435A1 (en) * 1981-07-31 1983-02-17 Rhodes, John Orally administrable pharmaceutical compositions
US5541170A (en) * 1981-07-31 1996-07-30 Tillotts Pharma Ag Orally administrable pharmaceutical compositions
US4540685A (en) * 1981-12-23 1985-09-10 Bauer Kurt H Process for the production of readily soluble 5-aminosalicylic acid preparations, compositions and methods of use
US4699902A (en) * 1981-12-23 1987-10-13 Bauer Kurt H Process for the production of readily soluble 5-aminosalicylic acid preparations
EP0291159A3 (en) * 1987-04-01 1993-03-17 Dak-Laboratoriet A/S Aminosalicylic-acid derivatives for the treatment of psoriasis
US5120306A (en) * 1990-03-21 1992-06-09 Gosselin Leon F Direct delivery of anti-inflammatories to the proximal small bowel
EP0554291A4 (en) * 1990-10-22 1993-09-08 Thomas Julius Borody Treatment of non-inflammatory and non-infectious bowel disorders
US5519014A (en) * 1990-10-22 1996-05-21 Borody; Thomas J. Treatment of non-inflammatory and non-infectious bowel disorders
JP3425441B2 (en) 1990-10-22 2003-07-14 ガストロ サービシイズ ピーティーワイ リミテッド Treatment of non-inflammatory and non-infectious bowel disorders
GB2253346A (en) * 1991-02-22 1992-09-09 John Rhodes Delayed release oral dosage forms for treatment of intestinal disorders

Also Published As

Publication number Publication date
GB2021409B (en) 1982-09-22

Similar Documents

Publication Publication Date Title
IT1230742B (en) COMPOSITION FOR AEROSOL INCLUDING NITROGLYCERINE AS ACTIVE INGREDIENT.
SE8700499D0 (en) NOVEL PHARMACOLOGICALLY ACTIVE COMPOUNDS
EG17753A (en) Novel pharmacological compounds
DE3069559D1 (en) Beta-carbolin-3-carboxylic acid derivatives, pharmaceutical compositions containing them and their therapeutical use
IL74707A0 (en) Anti-viral compositions comprising pyridazinamines,certain such novel compounds and their preparation
IE873125L (en) Benzimidazole derivatives
IE781032L (en) Pharmaceutical compositions
PH15114A (en) Propanone derivatives,and pharmaceutical composition containing this derivative as active ingredient
IT1190824B (en) PHARMACEUTICAL COMPOSITION CONTAINING 24.25-DIHYDROXICOLECALCIFEROL AS ACTIVE INGREDIENT
GB2006187B (en) Pharmaceutical compositions comprising heterocyclic compounds as active ingredient
JPS5321163A (en) Novel azolyllcarboxylic acid derivative* its preparation and fungicidal composition containing same as active ingredient
GB2021409A (en) Pharmaceutical composition
DE2966364D1 (en) Phenyl-alkanoic acid derivatives, the preparation thereof and pharmaceutical compositions containing them
AU530678B2 (en) Phosphono-hydroxy-acetic acid
IT8021550A0 (en) ADENOSINE DERIVATIVES WITH ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY AND THERAPEUTIC COMPOSITIONS WHICH CONTAIN THEM AS THE ACTIVE INGREDIENT.
IT1229223B (en) SYNERGISTICALLY ACTIVE VETERINARY COMPOSITIONS AND PROCEDURE FOR THEIR PREPARATION.
DE2860796D1 (en) Tantomeric arylaminoimidazoline derivatives, their preparation and pharmaceutical formulations for analgetic application containing them
GB2037289B (en) Nucleoside derivatives and an antileukemial agent containing the same as an active ingredient
JPS5297942A (en) Pseudotrisaccharide compound and medical compositions containing said compound as active ingredient
IT8919283A0 (en) PHARMACEUTICAL COMPOSITION INCLUDING AS ACTIVE INGREDIENT 3 N PIPERIDINOMETHYL AZINO METHYLRIFAMICIN S.
HUT50807A (en) Process for producing pharmaceutical compositions comprising labdane derivatives as active ingredient and for producing the active ingredient
IT8421627A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING THE ACTIVE INGREDIENT 24,25-DIIDROXYCHOLECALCIFEROL
SE8704049D0 (en) NOVEL PHARMACOLOGICAL COMPOUNDS
GB9005316D0 (en) Pharmaceutical composition comprising 3-(n-piperidinomethyl-azino)methylrifamycin s as active ingredient
GB8902069D0 (en) Pharmaceutical composition comprising 3-(n-piperidino-azino)methylrifamycin s as active ingredient

Legal Events

Date Code Title Description
PG Patent granted